COVID-19 Research

March 26, 2020

No items found.

‍Research funding opportunities related to COVID-19

On behalf of the Department of Health and Social Care, NIHR has established a single national process to prioritise and coordinate funding for COVID-19 research. This applies across all funded studies including public sector, industry and charity funding.

Information about this can be found here

Details of the process and the new single entry point can be found here

Application form is here

‍

UKRI Open Call – Research and innovation ideas to address COVID-19

IMI2 - Call 21 Development of therapuetics and diagnostics combatting coronavirus infections (closes 31 March 2020)

DASA COVID-19 Rapid sanitising technology for ambulances (closes 1st April 2020)

‍TechForce19 Supporting the elderley, vulnerable and self-isolating during COVID-19 (closes 1 April 2000)

LifeArc COVID-19 Development and testing of therapeutics (closes 6th April 2020)

Innovate UK Business-led innovation in response to global disruption (de minimis) (closes 17 April)

BSAC COVID-19 Supporting research projects (closes 17 April, simple application)

COVID-19 Therapeutics Accelerator Bill & Melinda Gates Foundation, Mastercard, Wellcome - contact: epidemics@wellcome.ac.uk for more infomation

Wellcome: Epidemic Preparedness COVID-19 (reviewing current proposals, may reopen)

‍

Are you researching COVID-19?

We love what all of our clients do. And we're always impressed by those working to tackle health care problems and save lives

So, at the moment we offer a FREE R&D Tax Credit Service for one year for organisations researching ways to tackle COVID-19 and its effects

We can also offer support with:

Identifying appropriate government support for your business
Bringing your year end forward so that you can file your R&D Tax Claim sooner
Free 1-2-1 support via the Innovate2succeed Programme
Plus a comprehensive range of other business support services
‍

‍Business Support Information

We've collated this list of links for businesses during this time

‍

We're here for an informal chat if you want to talk any of this through - just contact us using the details below

Call us on 01925 506100
Email us at info@inventya.com

Thanks for all that you're doing

‍

Image used in the header for this item:

Novel Coronavirus SARS-CoV-2. SEM showing SARS-CoV-2 (orange)—also known as 2019-nCoV, the virus that causes COVID-19 emerging from the surface of cells (green) cultured in the lab.
Credit: NIAID-RML

Downloaded from here cropped to size

‍

March 26, 2020

← back to news

Consultancy

Bid Writing

Thank you! We will be in touch shortly.

Oops! Something went wrong while submitting the form.

Your privacy matters | View our privacy policy

More of our news

The Human Element: Balancing Technology and Empathy in a Hyperconnected World

In our hyperconnected world, technology has transformed the way we communicate and interact with each other. From smartphones and social media to video calls and virtual reality, we rely on technology to connect with others, access information, and streamline our tasks. While technology and its evolution have undoubtedly brought many benefits, it has also led to concerns about the erosion of the human element in our interactions.

May 18, 2023

Unlocking the Power of International Collaboration: How Working with Partners Abroad Can Benefit Your R&D Activities

It's no secret that we're living in a hyperconnected world, where challenges can feel overwhelming as we huddle behind our screens. However, collaboration is the key that unlocks the door to enduring solutions, and we've witnessed this first-hand during the COVID-era. Global communities united to contain the spread, develop vaccines, and establish effective treatments. This joint effort played a crucial role in restoring a semblance of order amidst the chaos.

May 11, 2023

What to Consider When Choosing Your Grant Writer – the Importance of the Human Touch

Over the past two decades of writing grant applications, I've experienced the transformation of government funding. When InnovateUK was still called the 'Technology Strategy Board,' many businesses were unaware of available grants, and some were hesitant, thinking that such non-repayable funding was too good to be true.

May 3, 2023

Navigating the Ethical Crossroads: Striking the Balance between Grant Compliance and Innovation

In a world where market disruption and system modernisation are the norm, grant-funded projects face the challenge of balancing compliance and innovation. On the one hand, strict regulations ensure ethical conduct and resource allocation, while on the other, innovation is essential for solving complex problems and driving progress.

April 19, 2023

Unlocking the Potential of Sustainable Technologies: How R&D Tax Credits Can Pave the Way

Unlock the potential of sustainable technologies and pave the way towards a greener future with R&D Tax Credits. Learn how this government incentive can help your business reduce costs, improve cash flow, and drive innovation for environmental sustainability.

April 3, 2023

Common mistakes to avoid when writing a grant proposal

Key to writing a good grant proposal is to be diligent, focused and persistent. By avoiding common mistakes like lack of clarity, unrealistic budgeting, and failure to meet the funder’s priorities, you can increase your chances of getting grant approvals. Carefully plan your proposal while adhering to the submission guidelines and stay true to your project vision to bring your project to life.

March 14, 2023

COVID-19 Research

March 26, 2020

‍Research funding opportunities related to COVID-19

Are you researching COVID-19?

So, at the moment we offer a FREE R&D Tax Credit Service for one year for organisations researching ways to tackle COVID-19 and its effects

Image used in the header for this item:

Novel Coronavirus SARS-CoV-2. SEM showing SARS-CoV-2 (orange)—also known as 2019-nCoV, the virus that causes COVID-19 emerging from the surface of cells (green) cultured in the lab. Credit: NIAID-RML

Downloaded from here cropped to size

More of our news

Keep up to date with our latest news and updates

Read our privacy policy

Commercial Services

Innovate UK EDGE

Contact

Social Links

Other

Novel Coronavirus SARS-CoV-2. SEM showing SARS-CoV-2 (orange)—also known as 2019-nCoV, the virus that causes COVID-19 emerging from the surface of cells (green) cultured in the lab.
Credit: NIAID-RML